This is the text extract for Summary of NPPA Decisions: 1/3/2012-9/3/2012, browse documents here.
Report run 09 March, 2012 at 02:13:49 PM Panels NPPA Date from 1/03/2012 Date to 9/03/2012 Pathway UCC/UA Approved Declined HPC Approved Declined Pathway HPC HPC HPC UCC/UA UCC/UA Drug moxifloxacin moxifloxacin valaciclovir flucytosine cisapride
2 0 3 0 Indication multidrug-resistant streptococcus pneumoniae pneumonia bacteraemia, enterococcus faecalis infection gingivostomatitis, immunosuppressed patient, recurrent herpes simplex cryptococcal infection cerebral palsy, constipation, enteral feeds, pain Result Approved Approved Approved Approved Approved
Metadata
Title
Summary of NPPA Decisions: 1/3/2012-9/3/2012
Abstract
Report run 09 March, 2012 at 02:13:49 PM Panels NPPA Date from 1/03/2012 Date to 9/03/2012 Pathway UCC/UA Approved Declined HPC Approved Declined Pathway HPC HPC HPC UCC/UA UCC/UA Drug moxifloxacin moxifloxacin valaciclovir flucytosine cisapride 2 0 3 0 Indication…
Page 1
Note
This text has been extracted from the source PDF document.
Also available as plain text.
Please contact webmaster to discuss alternative format options.
